March 19 (Reuters) - CSL Ltd (CSL) :
- FERINJECT® APPROVED BY HEALTH CANADA FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN ADULT AND PEDIATRIC PATIENTS AND IRON DEFICIENCY IN ADULT PATIENTS WITH HEART FAILURE
- CSL LTD: IN CANADA, FERINJECT IS COMMERCIALIZED THROUGH CSL BEHRING CANADA, INC., WITH AVAILABILITY EXPECTED IN SECOND HALF OF 2024
News: CSL Ferinject Approved By Health Canada For The Treatment Of Iron Deficiency Anemia In Adult...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$278.06 |
Change
-0.140(0.05%) |
Mkt cap ! $133.9B | |||
| Open | High | Low | Value | Volume |
| $277.56 | $278.15 | $275.04 | $81.50M | 294.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 330 | $278.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $278.06 | 144 | 15 |
View Market Depth
| Last trade - 14.54pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$278.05 |
Change
-0.140 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $277.51 | $278.15 | $275.04 | 34760 | ||
| Last updated 15.12pm 30/05/2024 ? | |||||
| CSL (ASX) Chart |